Mapping 18F-fluorodeoxyglucose metabolism using PET/CT for the assessment of treatment response in non-small cell lung cancer patients undergoing epidermal growth factor receptor inhibitor treatment: a single-centre experience
Introduction: Specific mutations in the epidermal growth factor receptor (EGFR) characterize a subgroup of non-small cell lung cancer (NSCLC) patients that may be highly responsive to receptor inhibitor therapy. 18F-FDG PET/CT scans can map the glucose metabolism and treatment response of NSCLC. The...
|Main Authors:||, , ,|
Faculty of Medicine and Health Sciences, Universiti Putra Malaysia